المؤلفون: Salk, JJ, Loubet-Senear, K, Maritschnegg, E, Valentine, CC, Williams, LN, Higgins, JE, Horvat, R, Vanderstichele, A, Nachmanson, D, Baker, KT, Emond, MJ, Loter, E, Tretiakova, M, Soussi, T, Loeb, LA, Zeillinger, R, Speiser, P, Risques, RA

المصدر: Cell reports. 28(1):132

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:141300758

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Klapwijk JC; Cornelis Consulting Ltd, London, United Kingdom., Del Rio Espinola A; GentiBio Inc., Cambridge, Massachusetts, USA., Libertini S; Novartis Biomedical Research, Basel, Switzerland., Collin P; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Fellows MD; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Jobling S; TestaVec Ltd, Maidenhead, United Kingdom.; Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Lynch AM; GlaxoSmithKline, Genetic Toxicology, Ware, United Kingdom., Martus H; Novartis Biomedical Research, Basel, Switzerland., Vickers C; National Centre for the Replacement Refinement and Reduction of Animals in Research, London, United Kingdom., Zeller A; F. Hoffmann-La Roche Ltd., pRED, Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Biasco L; UCL Zayed Centre for Research (ZCR), London, United Kingdom., Brugman MH; Cell and Gene Therapy, GSK Medicine Research Centre, Stevenage, United Kingdom., Bushmann FD; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, Pennsylvania, USA., Cathomen T; Institute for Transfusion Medicine and Gene Therapy, Medical Center- University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Ertl HCJ; Ertl Laboratory, Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, USA., Gabriel R; ProtaGene CGT, Heidelberg, Germany., Gao G; Horae Gene Therapy Center, UMass Chan Medical School, University of Massachusetts, Worcester, Massachusetts, USA., Jadlowsky JK; Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kimber I; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Lanz TA; Drug Safety Research & Development, Pfizer, Inc., Groton, Connecticut, USA., Levine BL; Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Micklethwaite KP; Department of Haematology, Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, Australia.; NSW Health Pathology Blood Transplant and Cell Therapies Laboratory - ICPMR Westmead, Sydney, Australia.; Westmead Institute for Medical Research, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia., Onodera M; Gene & Cell Therapy Promotion Center, National Center for Child Health and Development, Tokyo, Japan., Pizzurro DM; Merck & Co., Inc., Boston, Massachusetts, USA., Reed S; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom., Rothe M; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Sabatino DE; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Salk JJ; Department of Medicine, Divisions of Hematology and Medical Oncology, University of Washington School of Medicine, Seattle, Washington, USA.; TwinStrand Biosciences Inc., Seattle, Washington, USA., Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Themis M; TestaVec Ltd, Maidenhead, United Kingdom.; Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Yuan J; Kymera Therapeutics, Watertown, Massachusetts, USA.

المصدر: Human gene therapy [Hum Gene Ther] 2024 Aug; Vol. 35 (15-16), pp. 527-542.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: M.A. Liebert Country of Publication: United States NLM ID: 9008950 Publication Model: Print Cited Medium: Internet ISSN: 1557-7422 (Electronic) Linking ISSN: 10430342 NLM ISO Abbreviation: Hum Gene Ther Subsets: MEDLINE

مواضيع طبية MeSH: Genetic Therapy*/adverse effects , Genetic Therapy*/methods, Humans ; Risk Factors ; Animals ; Genetic Vectors/adverse effects ; Consensus ; Neoplasms/therapy ; Neoplasms/genetics ; Risk Assessment

المؤلفون: Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Gui G; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Ravindra N; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Andrew G; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Mukherjee D; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Wong ZC; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland., Huang Y; Invivoscribe, San Diego, California., Gerhold J; Invivoscribe, San Diego, California., Holman M; Invivoscribe, San Diego, California., D'Angelo J; Invivoscribe, San Diego, California., Miller J; Invivoscribe, San Diego, California., Higgins J; TwinStrand Biosciences, Seattle, Washington., Salk JJ; TwinStrand Biosciences, Seattle, Washington.; University of Washington School of Medicine, Seattle., Auletta JJ; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.; The Ohio State University College of Medicine, Columbus., El Chaer F; University of Virginia, Charlottesville., Devine SM; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota., Jimenez-Jimenez AM; Sylvester Comprehensive Cancer Center, Miami, Florida., De Lima MJG; The Ohio State University College of Medicine, Columbus., Litzow MR; Mayo Clinic, Rochester, Minnesota., Kebriaei P; The University of Texas MD Anderson Cancer Center, Houston., Saber W; Medical College of Wisconsin, Milwaukee.; National Marrow Donor Program, Minneapolis, Minnesota., Spellman SR; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.; National Marrow Donor Program, Minneapolis, Minnesota., Zeger SL; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Page KM; Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.; Medical College of Wisconsin, Milwaukee., Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Virginia Tech Fralin Biomedical Research Institute Cancer Research Center, Washington, DC.

المصدر: JAMA oncology [JAMA Oncol] 2024 Aug 01; Vol. 10 (8), pp. 1104-1110.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Medical Association Country of Publication: United States NLM ID: 101652861 Publication Model: Print Cited Medium: Internet ISSN: 2374-2445 (Electronic) Linking ISSN: 23742437 NLM ISO Abbreviation: JAMA Oncol Subsets: MEDLINE

مواضيع طبية MeSH: fms-Like Tyrosine Kinase 3*/genetics , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/mortality , Leukemia, Myeloid, Acute*/blood , Hematopoietic Stem Cell Transplantation*/methods , Transplantation, Homologous* , Neoplasm, Residual*, Humans ; Female ; Male ; Middle Aged ; Adult ; Tandem Repeat Sequences ; Aged ; Gene Duplication ; Cohort Studies

المؤلفون: Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Higgins J; TwinStrand Biosciences, Seattle, WA., Nasif H; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA., Othus M; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA., Beppu L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Smith TH; TwinStrand Biosciences, Seattle, WA., Schmidt E; TwinStrand Biosciences, Seattle, WA., Valentine Iii CC; TwinStrand Biosciences, Seattle, WA., Salk JJ; TwinStrand Biosciences, Seattle, WA., Wood BL; Dept. of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, CA., Erba HP; Duke University School of Medicine, Durham, NC., Radich JP; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA., Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD; Myeloid Malignancies Program, National Institutes of Health, Bethesda, MD. hourigan@nih.gov.

المصدر: Haematologica [Haematologica] 2024 Feb 01; Vol. 109 (2), pp. 401-410. Date of Electronic Publication: 2024 Feb 01.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/diagnosis , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/therapy , Hematopoietic Stem Cell Transplantation*, Adult ; Humans ; Treatment Outcome ; Prognosis ; Recurrence ; Neoplasm, Residual/diagnosis ; Flow Cytometry/methods

المؤلفون: Smith-Roe SL; Division of Translational Toxicology, NIEHS, Research Triangle Park, NC, USA. Electronic address: stephanie.smith-roe@nih.gov., Hobbs CA; Integrated Laboratory Systems, LLC (An Inotiv Company), Research Triangle Park, NC, USA., Hull V; Integrated Laboratory Systems, LLC (An Inotiv Company), Research Triangle Park, NC, USA., Todd Auman J; Integrated Laboratory Systems, LLC (An Inotiv Company), Research Triangle Park, NC, USA., Recio L; Integrated Laboratory Systems, LLC (An Inotiv Company), Research Triangle Park, NC, USA., Streicker MA; Integrated Laboratory Systems, LLC (An Inotiv Company), Research Triangle Park, NC, USA., Rivas MV; Integrated Laboratory Systems, LLC (An Inotiv Company), Research Triangle Park, NC, USA., Pratt GA; TwinStrand Biosciences, Inc., Seattle, WA, USA., Lo FY; TwinStrand Biosciences, Inc., Seattle, WA, USA., Higgins JE; TwinStrand Biosciences, Inc., Seattle, WA, USA., Schmidt EK; TwinStrand Biosciences, Inc., Seattle, WA, USA., Williams LN; TwinStrand Biosciences, Inc., Seattle, WA, USA., Nachmanson D; TwinStrand Biosciences, Inc., Seattle, WA, USA., Valentine Iii CC; TwinStrand Biosciences, Inc., Seattle, WA, USA., Salk JJ; TwinStrand Biosciences, Inc., Seattle, WA, USA., Witt KL; Division of Translational Toxicology, NIEHS, Research Triangle Park, NC, USA.

المصدر: Mutation research. Genetic toxicology and environmental mutagenesis [Mutat Res Genet Toxicol Environ Mutagen] 2023 Oct; Vol. 891, pp. 503669. Date of Electronic Publication: 2023 Aug 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101632149 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3592 (Electronic) Linking ISSN: 13835718 NLM ISO Abbreviation: Mutat Res Genet Toxicol Environ Mutagen Subsets: MEDLINE

مواضيع طبية MeSH: Ethylnitrosourea*/toxicity , Nitrosourea Compounds*, Rats ; Male ; Animals ; Reproducibility of Results ; Rats, Sprague-Dawley ; Mutagenesis ; Mutation ; Mutagens/toxicity

المؤلفون: Lynch AM; GSK R&D, Stevenage, United Kingdom.; School of Medicine, Swansea University, Swansea, United Kingdom., Zanoni TB; TwinStrand Biosciences, Seattle, WA, United States., Salk JJ; TwinStrand Biosciences, Seattle, WA, United States.; Division of Medical Oncology, University of Washington, Seattle, WA, United States.; Fred Hutch Cancer Center, Seattle, WA, United States., Martincorena I; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, United Kingdom., Young RR; TwinStrand Biosciences, Seattle, WA, United States., Kucab J; Genetic and Environmental Toxicology, King's College, London, United Kingdom., Valentine CC; TwinStrand Biosciences, Seattle, WA, United States., Yauk C; Department of Biology, University of Ottawa, Ottawa, ON, Canada., Escobar PA; Merck & Co. InC., Rahway, NJ, United States., Witt KL; National Institute of Environmental Health Sciences, Division of Translational Toxicology, Research Triangle Park, NC, United States., Frötschl R; Federal Institute for Drugs and Medical Devices (Bundesinstitiut für Arzneimittel und Medizinprodukte), Bonn, Germany., Reed SH; School of Medicine, Division of Cancer and Genetics, Cardiff University, Cardiff, CF14 4XN, United Kingdom., Ashford A; Safety Innovation, Safety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, United Kingdom.

المصدر: Mutagenesis [Mutagenesis] 2023 Aug 24; Vol. 38 (4), pp. 192-200.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 8707812 Publication Model: Print Cited Medium: Internet ISSN: 1464-3804 (Electronic) Linking ISSN: 02678357 NLM ISO Abbreviation: Mutagenesis Subsets: MEDLINE

مواضيع طبية MeSH: High-Throughput Nucleotide Sequencing* , Mutagens*, Animals ; Humans ; London ; Mutagenesis ; Mutation ; Carcinogenesis ; Genomics

المؤلفون: Dodge AE; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada.; Department of Biology, University of Ottawa, Ottawa, Ontario, Canada., LeBlanc DPM; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada., Zhou G; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada., Williams A; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada., Meier MJ; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada., Van P; TwinStrand Biosciences Inc., Seattle, Washington, USA., Lo FY; TwinStrand Biosciences Inc., Seattle, Washington, USA., Valentine Iii CC; TwinStrand Biosciences Inc., Seattle, Washington, USA., Salk JJ; TwinStrand Biosciences Inc., Seattle, Washington, USA., Yauk CL; Department of Biology, University of Ottawa, Ottawa, Ontario, Canada. carole.yauk@uottawa.ca.; Department of Biology, Carleton University, Ottawa, Ontario, Canada. carole.yauk@uottawa.ca., Marchetti F; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada. francesco.marchetti@hc-sc.gc.ca.; Department of Biology, Carleton University, Ottawa, Ontario, Canada. francesco.marchetti@hc-sc.gc.ca.

المصدر: Archives of toxicology [Arch Toxicol] 2023 Aug; Vol. 97 (8), pp. 2245-2259. Date of Electronic Publication: 2023 Jun 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0417615 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0738 (Electronic) Linking ISSN: 03405761 NLM ISO Abbreviation: Arch Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Mutation Rate* , Bone Marrow*, Male ; Mice ; Animals ; Procarbazine/toxicity ; Mutagens/toxicity ; Mutation ; Mutagenicity Tests/methods ; Mice, Transgenic ; Lac Operon

المؤلفون: Marchetti F; Health Canada, Ottawa, ON, Canada., Cardoso R; MilliporeSigma, Rockville, MD, USA., Chen CL; Health and Environmental Sciences Institute, Washington, DC, USA. Electronic address: cchen@hesiglobal.org., Douglas GR; Health Canada, Ottawa, ON, Canada., Elloway J; Safety Sciences, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Escobar PA; Merck & Co., Rahway, NJ, USA., Harper T Jr; Amgen Research, Amgen Inc, Thousand Oaks, CA, USA., Heflich RH; US Food and Drug Administration/National Center for Toxicological Research, Jefferson, AR, USA., Kidd D; Labcorp Early Development Laboratories Limited, Harrogate, North Yorkshire, UK., Lynch AM; GSK R&D, Stevenage, UK., Myers MB; US Food and Drug Administration/National Center for Toxicological Research, Jefferson, AR, USA., Parsons BL; US Food and Drug Administration/National Center for Toxicological Research, Jefferson, AR, USA., Salk JJ; TwinStrand Biosciences Inc., Seattle, WA, USA., Settivari RS; Corteva Agriscience, Newark, DE, USA., Smith-Roe SL; NIEHS, Division of the National Toxicology Program, Research Triangle Park, NC, USA., Witt KL; NIEHS, Division of the National Toxicology Program, Research Triangle Park, NC, USA., Yauk CL; University of Ottawa, Ottawa, ON, Canada., Young R; MilliporeSigma, Rockville, MD, USA; Current: Consultant, Bethesda, MD, USA., Zhang S; Pfizer Inc., Groton, CT, USA., Minocherhomji S; Amgen Research, Amgen Inc, Thousand Oaks, CA, USA; Current: Eli Lilly and Company, Indianapolis, IN, USA.

المصدر: Mutation research. Reviews in mutation research [Mutat Res Rev Mutat Res] 2023 Jul-Dec; Vol. 792, pp. 108466. Date of Electronic Publication: 2023 Aug 27.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Science B.V Country of Publication: Netherlands NLM ID: 101632211 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1388-2139 (Electronic) Linking ISSN: 13835742 NLM ISO Abbreviation: Mutat Res Rev Mutat Res Subsets: MEDLINE

مواضيع طبية MeSH: High-Throughput Nucleotide Sequencing*/methods , Mutagens*/toxicity, Humans ; Mutagenicity Tests ; Mutation ; Carcinogens/toxicity ; Carcinogenesis ; Risk Assessment

المؤلفون: Cho E; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada; Department of Biology, Carleton University, Ottawa, ON, Canada., Swartz CD; Inotiv-RTP, Research Triangle Park, NC, USA., Williams A; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada., V Rivas M; Inotiv-RTP, Research Triangle Park, NC, USA., Recio L; Inotiv-RTP, Research Triangle Park, NC, USA; Scitovation, Research Triangle Park, NC, USA., Witt KL; Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA., Schmidt EK; TwinStrand Biosciences, Inc., Seattle, WA, USA., Yaplee J; TwinStrand Biosciences, Inc., Seattle, WA, USA., Smith TH; TwinStrand Biosciences, Inc., Seattle, WA, USA., Van P; TwinStrand Biosciences, Inc., Seattle, WA, USA., Lo FY; TwinStrand Biosciences, Inc., Seattle, WA, USA., Valentine CC 3rd; TwinStrand Biosciences, Inc., Seattle, WA, USA., Salk JJ; TwinStrand Biosciences, Inc., Seattle, WA, USA., Marchetti F; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada; Department of Biology, Carleton University, Ottawa, ON, Canada., Smith-Roe SL; Division of Translational Toxicology, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA. Electronic address: stephanie.smith-roe@nih.gov., Yauk CL; Environmental Health Science and Research Bureau, Health Canada, Ottawa, ON, Canada; Department of Biology, Carleton University, Ottawa, ON, Canada; Department of Biology, University of Ottawa, Ottawa, ON, Canada. Electronic address: Carole.Yauk@uottawa.ca.

المصدر: Mutation research. Genetic toxicology and environmental mutagenesis [Mutat Res Genet Toxicol Environ Mutagen] 2023 Jul; Vol. 889, pp. 503649. Date of Electronic Publication: 2023 May 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101632149 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3592 (Electronic) Linking ISSN: 13835718 NLM ISO Abbreviation: Mutat Res Genet Toxicol Environ Mutagen Subsets: MEDLINE

مواضيع طبية MeSH: Mutagens*/toxicity , DNA*, Humans ; Reproducibility of Results ; Mutation ; Mutagenesis ; Ethylnitrosourea